Showing results (51-60 of 205) with videos related to
Sort By:
Pageof 21
Clinical Neuropharmacology|March 1, 1983
The dexamethasone suppression test in depressionH S Green, J M KaneInternational Pharmacopsychiatry|January 1, 1980
A controlled trial of oxypertine in tardive dyskinesiaH L Freeman, S D Soni, L CarpenterJournal of Neuroscience Research|September 22, 2020
Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disordersCynthia J M Kane, Paul D DrewJournal of Clinical & Cellular Immunology|February 17, 2017
Peroxisome Proliferator-Activated Receptor-γ Agonists: Potential Therapeutics for Neuropathology Associated with Fetal Alcohol Spectrum DisordersPaul D Drew, Cynthia J M KaneL'Encephale|September 1, 1988
Epidemiological aspects of tardive dyskinesiaJ M Kane, M Woerner, J LiebermanThe Journal of Clinical Psychiatry|May 1, 1986
Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimensJ M Kane, M Woerner, S SarantakosInternational Review of Neurobiology|September 2, 2014
Fetal alcohol spectrum disorders and neuroimmune changesPaul D Drew, Cynthia J M KaneCurrent Medicinal Chemistry|November 17, 2004
Therapeutic potential of natural compounds that regulate the activity of protein kinase CCharleata A Carter, Cynthia J M KaneJournal of Leukocyte Biology|July 28, 2016
Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologiesCynthia J M Kane, Paul D DrewPsychopharmacology. Supplementum|January 1, 1985
Tardive dyskinesia: prevalence, incidence, and risk factorsJ M Kane, M Woerner, J LiebermanPageof 21